ALL (ASX) Huge Broker Upgrades- Will Fly!

Originally posted by Pary ↑

Charlie Aitken has SP at plus $40 on ALL - the article published on Switzer today:

Aristocrat Leisure – a $40 plus stock

By Charlie Aitken 23 August | 2018

Chief Investment Officer and founder of Aitken Investment Management

A A A

While I am broadly cautious on Australia’s top 20 stocks by market cap, because I just can’t see further near-term upside, there do remain pockets of growth at a reasonable price in larger mid-caps with global leverage.
Today I thought, after making the points above, I’d keep going with the series of high conviction stocks I have in Australia. HUB24 had a nice bounce on fundamentals, Kidman is trying to bottom after a 50% fall, CYB looks great value versus domestic growthless banks, and Aristocrat (ALL) remains my largest Australian holding.
Aristocrat has done nothing for a while but, in my view, this is just a consolidation of recent gains before the next leg up. This remains the world leader of its industry and is due further re-rating.
Aristocrat has broadly traded sideways since the end of May. This is somewhat surprising considering it delivered a tremendous result that triggered earnings upgrades. Those upgrades are reflected in the chart below.
The Aristocrat share price capital rewards have matched the structural earnings per share growth. Below is an overall of FY18 EPS forecasts (RED LINE) from Aristocrat analysts and the Aristocrat share price over the last five years. You can see the close correlation as EPS estimates were consistently upgraded as management delivered on their growth strategy.

Earnings per share growth (OR NOT). That is the key to successful stock picking. EPS growth drives DPS growth. Never look at yield first. Never: dividend yield is an output, not an input.
Three more strong years
Back to Aristocrat and I see three more strong years of earnings per share growth and a pathway to a $40.00 plus share price.
Aristocrat’s transformation from a straight gaming/slots play, contingent on the replacement cycle, to a content/social gaming provider continues. With the company still in the early stages of the build out of a digital game business of scale, earnings risk lies to the upside, given the greater exposure to this fast-growing market and ‘learning synergies’ the company already appears to be extracting from recent acquisitions. Amazingly, or as a result of the consistent earnings growth, the stock’s PE has barely moved over the last two years, despite the near vertical share price delivering 27% 3YR EPS compound annual growth rate (CAGR) on a 20 times PE, Aristocrat occupies a unique niche in the Australian market, where you generally see domestics pay a much higher multiple for this quantum of earnings growth.

Analysts generally upgraded Aristocrat forecasts by 7% to 10% after the first half earnings beat. The stock price responded in line with the consensus earnings upgrades, but to me, the next leg of this for Aristocrat is P/E expansion, as the world starts to price the company as a software as a service/ platform business, with 70% recurring earnings, and not as poker machine cabinet maker. I think Aristocrat’s P/E can rise to 25 times to reflect the change in its business and its position as the world leader in its sector.
$40.00 plus stock
Let’s assume Aristocrat generates EPS of $1.35 in FY19 and $1.75 in FY20. Put both those EPS estimates on 25 times and we set a price target range of $33.75 to $43.75 over the next two years. I absolutely believe, and am positioned for, Aristocrat being a $40.00 plus stock. If we are right about our EPS forecasts, which I actually think will prove conservative and be upgraded, and right about our view on P/E expanding over the next two years, then I see Aristocrat continuing to be one of the handful of global structural growth stocks that lead the ASX, while domestic exposures struggle.
The AS&P/ASX 200 is 2.5% of the world equity market and Australia has just 24 million of the world’s 7.2 billion people. It’s very hard to drive earnings growth from an addressable market of just 24 million people. I think you want to be investing in stocks with the biggest addressable marketplace. That either means they face Asia or the USA, or preferably both.
I invest in stocks that sell their product or service to the world, not just to 24 million people. I believe all of you need more global exposure in your portfolio and one of my key high conviction ASX-listed global earning ideas remains Aristocrat Leisure (ALL).
Aristocrat passed the earnings and outlook test and has all the characteristics we seek in a high conviction investment. As I said, we’ve increased our investment in Aristocrat post the result and consensus earnings upgrades.
In summary, I think it’s time to be cautious on large-cap, growthless, S&P/ASX 200 leading stocks that have driven up on non-fundamental reasons, such as US dollar strength.
Remember, in the short term, the market is a voting machine. In the long-term it’s a weighing machine. My view is to take profits in S&P/ASX 200 stocks that have risen because of a short-term popular trade, and rotate to those that have structural earnings growth and valuation upside.
Important: This content has been prepared without taking account of the objectives, financial situation or needs of any particular individual. It does not constitute formal advice. Consider the appropriateness of the information in regard to your circumstances.

Expand

Eleven unnamed analysts tracked by Lincoln Indicators results in an average share price consensus of $34.26 as at today's date when the stock closed up at $30.95.

Does anyone have access to other broker or analysts reports ??

No.	Vol.	Price($)
1	1948	$51.52

No.

Vol.

Price($)

1948

$51.52

Price($)	Vol.	No.
$51.55	12383	2

Price($)

Vol.

No.

$51.55

12383

No.	Vol.	Price($)
1	1948	51.520
1	9367	51.410
1	2047	51.380
1	1846	51.340
1	1601	51.310

No.

Vol.

Price($)

1948

51.520

9367

51.410

2047

51.380

1846

51.340

1601

51.310

Price($)	Vol.	No.
51.660	3274	2
51.780	20000	1
51.870	35	1
51.910	2929	1
51.950	500	1

Price($)

Vol.

No.

51.660

3274

51.780

20000

51.870

51.910

2929

51.950

500

(20min delay)
Last $51.52		Change 0.870(1.72%)		Mkt cap ! $32.57B

Open	High	Low	Value	Volume
$51.10	$51.85	$50.60	$57.61M	1.117M

Eleven unnamed analysts tracked by Lincoln Indicators results in...

Patagonia looks to raise $2.15M for South American exploration and development

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Eleven unnamed analysts tracked by Lincoln Indicators results in...

Top Stories

Patagonia looks to raise $2.15M for South American exploration and development

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News